No Data
No Data
No Data
No Data
No Data
Femasys: A Buy Rating on Innovative Reproductive Solutions and Market Expansion Potential
TipRanksApr 2 15:45 ET
Femasys Price Target Maintained With a $12.00/Share by Chardan Capital
Femasys Price Target Maintained With a $12.00/Share by Chardan Capital
Dow JonesApr 1 08:35 ET
Femasys Is Maintained at Buy by HC Wainwright & Co.
Femasys Is Maintained at Buy by HC Wainwright & Co.
Dow JonesApr 1 06:54 ET
HC Wainwright & Co. Maintains Buy on Femasys, Raises Price Target to $12
HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and raises the price target from $10 to $12.
BenzingaApr 1 06:43 ET
Femasys Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo FinanceMar 31 09:06 ET
Femasys Q4 EPS $(0.19) Beats $(0.21) Estimate, Sales $213.11K Miss $240.00K Estimate
Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.21) by 9.52 percent. This is a 20.83 percent increase over losses of $(0.24) per s
BenzingaMar 28 23:38 ET
No Data
No Data